CORTEXA
← Browse

Ashok H Akabari

3 papers indexed

openalexJournal of Chemical Metrology2023-10-10Cited by 1

Simultaneous determiantion of aripiprazole and escitalopram oxalate by HPLC

Divyakumari Kiransinh Solanki, Sagarkumar P. Patel, Jasmina Surati, Ashok H Akabari, Ketan Shah, Dipansu Sahu, et al.

Simple, accurate, precise, and sensitive reverse-phase high-performance liquid chromatographic (HPLC) method was developed for the simultaneous measurement of ARI and ESC in pharmaceutical products by using a C18 column with dimensions of 250 mm x 4.6 mm and a particle size of 5…

Also available via: ACG Publications

View free PDFSource page
openalexJournal of Phytonanotechnology and Pharmaceutical Sciences2023-09-01Cited by 9

Emerging therapies and management approaches in sickle cell disease (SCD): A critical review

Sagarkumar Patel, Rachna Patel, Srinivasa Reddy Mukkala, Ashok H Akabari

This comprehensive review delves into the intricate landscape of sickle cell disease (SCD), a global genetic disorder impacting individuals, healthcare systems, and communities.The article traces the historical origins of SCD, providing an in-depth exploration of its complex path…

Also available via: Journal of Phytonanotechnology and Pharmaceutical Sciences

View free PDFSource page
openalex2023-03-14

IMMUNOGENICITY IN PRECLINICAL DRUG DEVELOPMENT: STRATEGIES, RISKS, AND IMPLICATIONS FOR LARGE MOLECULE-BASED BIOLOGICS INCLUDING CAR T-CELL AND GENE THERAPIES

Sagarkumar Patel, Rachna Patel, Ashok H Akabari

Immunogenicity is a critical consideration in developing therapeutic agents, particularly in large molecule-based biologics, CAR T-cell therapies, and gene therapies. This comprehensive review delves into the multifaceted landscape of immunogenicity, elucidating its definition an…

Also available via: OpenAlex

View free PDFSource page